These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32123937)

  • 1. International Regensburg Center for Interventional Immunology (RCI) symposium on "Synthetic immunology and environment-adapted redirection of T cells", 17-18 July, 2019, Regensburg, Germany.
    Beckhove P; Edinger M; Feuerer M; Gattinoni L; Abken H
    Cancer Immunol Immunother; 2020 Apr; 69(4):677-682. PubMed ID: 32123937
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases.
    Chen Y; Sun J; Liu H; Yin G; Xie Q
    J Immunol Res; 2019; 2019():5727516. PubMed ID: 32083141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Tailoring of Regulatory T Cells Prior to Cell Therapy.
    Baeten P; Hellings N; Broux B
    Trends Mol Med; 2020 Nov; 26(11):1059-1060. PubMed ID: 32978063
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants?
    Bayry J; Lacroix-Desmazes S; Dasgupta S; Kazatchkine MD; Kaveri SV
    Nat Rev Immunol; 2008 Jan; 8(1):1p following 86; author reply 1p following 86. PubMed ID: 18049489
    [No Abstract]   [Full Text] [Related]  

  • 5. The Future of CAR T Therapeutics to Treat Autoimmune Disorders.
    Pecher AC; Hensen L; Lengerke C; Henes J
    Mol Diagn Ther; 2024 Sep; 28(5):593-600. PubMed ID: 39078456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Armed T cells with CAR for cancer immunotherapy.
    Wei YQ
    Sci China Life Sci; 2016 Apr; 59(4):331-2. PubMed ID: 27080712
    [No Abstract]   [Full Text] [Related]  

  • 7. Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors.
    Harris DT; Kranz DM
    Trends Pharmacol Sci; 2016 Mar; 37(3):220-230. PubMed ID: 26705086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T
    Raffin C; Vo LT; Bluestone JA
    Nat Rev Immunol; 2020 Mar; 20(3):158-172. PubMed ID: 31811270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What does the future hold for cell-based tolerogenic therapy?
    Bluestone JA; Thomson AW; Shevach EM; Weiner HL
    Nat Rev Immunol; 2007 Aug; 7(8):650-4. PubMed ID: 17653127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy: HSCT-resetting immune tolerance by boosting TREG cell diversity.
    Duarte JH
    Nat Rev Rheumatol; 2015 Dec; 11(12):681. PubMed ID: 26526646
    [No Abstract]   [Full Text] [Related]  

  • 11. Chimeric antigen receptor transduced T cells: Tuning up for the next generation.
    Schubert ML; Hoffmann JM; Dreger P; Müller-Tidow C; Schmitt M
    Int J Cancer; 2018 May; 142(9):1738-1747. PubMed ID: 29119551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redirected T cells in cancer therapy.
    Sangiolo D
    Expert Opin Biol Ther; 2015; 15(12):1667-70. PubMed ID: 26515608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells.
    de Zoeten EF; Hancock WW
    Gastroenterology; 2008 Jun; 134(7):2171-4. PubMed ID: 18482583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Comte D
    Rev Med Suisse; 2024 Jun; 20(877):1139. PubMed ID: 38836401
    [No Abstract]   [Full Text] [Related]  

  • 15. T cell subtypes and its therapeutic potential in autoimmune diseases and cancer.
    Awasthi A; Kumar H
    Int Rev Immunol; 2019; 38(5):181-182. PubMed ID: 31608783
    [No Abstract]   [Full Text] [Related]  

  • 16. CAR T Cell Therapy for Solid Tumors.
    Newick K; O'Brien S; Moon E; Albelda SM
    Annu Rev Med; 2017 Jan; 68():139-152. PubMed ID: 27860544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune cell therapy using iPS cells].
    Yano H; Kaneko S
    Rinsho Ketsueki; 2018; 59(2):225-231. PubMed ID: 29515078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic targets of CAR T Cell Therapy. A retrospective view on clinical trials.
    Arabi F; Torabi-Rahvar M; Shariati A; Ahmadbeigi N; Naderi M
    Exp Cell Res; 2018 Aug; 369(1):1-10. PubMed ID: 29758187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How antigen specificity directs regulatory T-cell function: self, foreign and engineered specificity.
    Hoeppli RE; MacDonald KG; Levings MK; Cook L
    HLA; 2016 Jul; 88(1-2):3-13. PubMed ID: 27256587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing guidelines for CAR-T cells: challenges and considerations.
    Wang W; Qin DY; Zhang BL; Wei W; Wang YS; Wei YQ
    Sci China Life Sci; 2016 Apr; 59(4):333-9. PubMed ID: 26965523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.